文献速递哮喘

痰基因表达特征可预测哮喘口服糖皮质激素反应

A sputum gene expression signature predicts oral corticosteroid response in asthma.
PubMed 文献 · Eur Respir J · 2017-06-29

研究纳入55例稳定期哮喘成人,进行50 mg泼尼松每日10天的随机交叉试验,评估诱导痰六基因表达特征及血/痰嗜酸粒细胞对口服糖皮质激素反应的预测价值。结果显示应答者基线CPA3表达上调、肺功能更差、血及痰嗜酸粒细胞更高,六基因特征预测临床显著反应的ROC表现优于血和痰嗜酸粒细胞。

要点

  • 稳定期哮喘患者中,痰六基因表达特征预测口服糖皮质激素反应优于血和痰嗜酸粒细胞。
  • 应答者基线特征包括CPA3表达上调、肺功能更差及血/痰嗜酸粒细胞增高。
  • 治疗后CLC和CPA3表达下降,提示肥大细胞在哮喘中可能发挥额外作用。

核心结论

  • 包含嗜酸粒细胞和Th2相关肥大细胞标志物的六基因痰表达特征,预测稳定期哮喘口服糖皮质激素反应较血和痰嗜酸粒细胞更精确。

研究设计与样本

  • 随机对照交叉试验,55例稳定期哮喘成人接受50 mg泼尼松每日10天治疗。

主要发现

  • 应答者(n=25)基线CPA3基因表达上调、肺功能更差、痰和血嗜酸粒细胞更高。
  • 治疗后CLC和CPA3表达降低,DNASE1L3、IL1B、ALPL和CXCR2表达不变。
  • ROC分析显示六基因表达特征预测口服糖皮质激素临床显著反应优于血和痰嗜酸粒细胞。

关键数值与推荐

  • 六基因特征包括CLC、CPA3、DNASE1L3、IL1B、ALPL和CXCR2。
  • 反应指标包括ΔFEV1、ΔACQ6或ΔFeNO的变化。

临床怎么用

  • 痰六基因表达特征可能有助于指导稳定期哮喘的口服糖皮质激素治疗选择。
  • 该特征提示肥大细胞在哮喘中可能具有额外作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Biomarkers that predict responses to oral corticosteroids (OCS) facilitate patient selection for asthma treatment. We hypothesised that asthma patients would respond differently to OCS therapy, with biomarkers and inflammometry predicting response.Adults with stable asthma underwent a randomised controlled cross-over trial of 50 mg prednisolone daily for 10 days (n=55). A six-gene expression biomarker signature (CLC, CPA3, DNASE1L3, IL1B, ALPL and CXCR2) in induced sputum, and eosinophils in blood and sputum were assessed and predictors of response were investigated (changes in forced expiratory volume in 1 s (ΔFEV1), six-item Asthma Control Questionnaire score (ΔACQ6) or exhaled nitric oxide fraction (ΔFeNO)).At baseline, responders to OCS (n=25) had upregulated mast cell CPA3 gene expression, poorer lung function, and higher sputum and blood eosinophils. Following treatment, CLC and CPA3 gene expression was reduced, whereas DNASE1L3, IL1B, ALPL and CXCR2 expression remained unchanged. Receiver operating characteristic (ROC) analysis showed the six-gene expression biomarker signature as a better predictor of clinically significant responses to OCS than blood and sputum eosinophils.The six-gene expression signature including eosinophil and Th2 related mast cell biomarkers showed greater precision in predicting OCS response in stable asthma. Thus, a novel sputum gene expression signature highlights an additional role of mast cells in asthma, and could be a useful measurement to guide OCS therapy in asthma.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Berthon BS, Gibson PG, Wood LG, et al. A sputum gene expression signature predicts oral corticosteroid response in asthma. Eur Respir J. 2017. PMID: 28663317. doi:10.1183/13993003.00180-2017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。